Biocept Inc (BIOC) stock is down -87.83% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives BIOC stock a score of 43 out of a possible 100.
That score is chiefly influenced by a long-term technical score of 2. BIOC’s score also includes a short-term technical score of 52. The fundamental score for BIOC stock is 74. In addition to the average rating from Wall Street analysts, BIOC stock has a mean target price of $5.13. This means analysts expect the stock to add 346.09% over the next 12 months.
What’s Happening with BIOC Stock Today
Biocept Inc (BIOC) stock is lower by -6.5% while the S&P 500 is up 0.11% as of 10:46 AM on Wednesday, Mar 27. BIOC stock is down -$0.08 from the previous closing price of $1.23 on volume of 2,121,140 shares. Over the past year the S&P 500 has risen 6.13% while BIOC is down -87.83%. BIOC stock lost -$20.91 per share in the over the last 12 months.